Biotech News

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Integra LifeSciences (IART)Integra LifeSciencesConference / presentation

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech

Related news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

Stock data

Close
17.10 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States